Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Assemblybioinc in South San Francisco is seeking a Director, DMPK to lead drug metabolism and pharmacokinetics efforts. The successful candidate will oversee a team of external DMPK scientists and provide guidance on chemical lead optimization for drug development
Summary: We are seeking an experienced, creative, and highly motivated expert with industry research experience in DMPK focused on small molecule lead optimization for discovery research programs, preclinical and clinical drug development. In addition to overseeing a
Merck & Co., Inc. in San Francisco invites applications for a Senior Principal Scientist to provide scientific leadership across drug conjugate discovery and development, enabling data-driven decisions from discovery through nomination and FIH execution. The role
A clinical-stage biopharmaceutical company in California seeks an experienced Associate/Director of Analytical Development to lead analytical strategies for small molecules. The role demands a PhD in Analytical Chemistry and over 10 years of relevant experience. Responsibilities
Alumis Inc. is a precision medicines company with the mission to transform the lives of patients with autoimmune diseases. Even with treatment innovations of the last two decades, many patients with immunologic conditions continue to suffer
Zai Lab (US) LLC is looking for a Principal Scientist DMPK in South San Francisco. This senior role involves the design and execution of DMPK studies crucial for drug discovery and development. Candidates should have a PhD and
Job Description The Principal Scientist, DMPK, is a senior scientific contributor who provides expert support to drug discovery and development programs. This role focuses on designing and executing DMPK studies, interpreting data, and collaborating cross-functionally, while aligning with
GondolaBio, located in Palo Alto, CA, is seeking an experienced DMPK and Clinical Pharmacology Scientist to lead the development of antisense oligonucleotide therapeutics. The role involves defining and executing PK/PD strategies for intrathecal delivery systems, engaging in
Alumis Inc. in South San Francisco, CA, invites a Director of Clinical Pharmacology & DMPK to lead clinical pharmacology strategy and PK/PD modeling for small‑molecule programs in immune‑mediated diseases. You will partner with cross‑functional teams and report
POSITION SUMMARY Position Title: Director, DMPK Reports to: Executive Director, DMPK Status: Regular, Full-time, Exempt Location: South San Francisco, CA Summary: We are seeking an experienced, creative, and highly motivated expert with industry research experience in DMPK focused on
Merck in South San Francisco seeks a Senior Principal Scientist to lead DMPK strategy for drug conjugates and emerging modalities. You will collaborate across discovery biology, translational sciences, clinical development, and toxicology to enable data-driven decisions from
Assembly Bio seeks an experienced DMPK leader to oversee a group of external scientists and work closely with medicinal chemistry to optimize DMPK properties of lead candidates. You will guide DMPK strategies across discovery to clinical development, ensuring robust
Alumis Inc. is a precision medicines company with the mission to transform the lives of patients with autoimmune diseases. Even with treatment innovations of the last two decades, many patients with immunologic conditions continue to suffer
Merck & Co. in South San Francisco seeks a Senior Principal Scientist to provide scientific leadership across drug conjugate discovery and development programs, guiding DMPK strategy and translating data to decision points from discovery through FIH execution.
DMPK Director The DMPK Director has strong scientific, technical and leadership skills to develop and implement DMPK and modeling & simulation strategies to advance drug candidates from discovery to development stage and build comprehensive DMPK packages to enable successful drug
Evommune, Inc. (NYSE: EVMN) is a clinical‑stage biotechnology company focused on developing innovative therapies for immune‑mediated inflammatory diseases. Headquartered in Palo Alto, California, with additional operations in New York, NY, Evommune is advancing a differentiated pipeline
Initial Therapeutics, Inc. is seeking a Director of Clinical Pharmacology & DMPK in South San Francisco. This role will drive clinical pharmacology strategy for small-molecule programs aimed at treating immune-mediated diseases. The ideal candidate will have a
GondolaBio is a clinical‑stage biopharmaceutical company focused on developing breakthrough therapeutics for genetic diseases. GondolaBio is an independent sister company to BridgeBio, carved out in 2024 after securing $300M in private financing from external investors. The
A leading IT staffing company based in South San Francisco is looking for a skilled bioanalytical chemist. This role involves conducting in vitro ADME assays, developing quantitative methods using LC-MS/MS, and collaborating closely with senior scientists